Extract

This trial is conducted in Asia, Europe, Japan and North America. The aim of this clinical trial is to investigate the safety and the efficacy of a prophylactic treatment option with long acting coagulation factor VII (LA-rFVIIa) for haemophilia patients with inhibitors.

Inclusion criteria

• Congenital Bleeding Disorder ,Haemophilia A With Inhibitors ,Haemophilia B With Inhibitors

Country

• France
• Japan
• Malaysia
• Serbia
• South Africa
• Sweden
• Turkey
• United Kingdom
• United States

Links

• ictrp
• nct